D
TScan Therapeutics, Inc. TCRX
$1.82 $0.084.60% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 473.88% 283.57% -90.78% -73.01% -82.97%
Total Other Revenue -- -- -- -- --
Total Revenue 473.88% 283.57% -90.78% -73.01% -82.97%
Cost of Revenue 21.42% 19.84% -16.35% 15.48% 26.62%
Gross Profit -12.21% -13.69% 5.33% -33.73% -45.70%
SG&A Expenses 17.01% 21.90% 30.20% 25.70% 19.02%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 20.43% 20.29% 30.84% 17.59% 24.83%
Operating Income -13.31% -15.55% -71.90% -31.82% -38.62%
Income Before Tax -16.71% -13.22% -82.58% -29.96% -31.67%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -16.71% -13.22% -82.58% -29.96% -31.67%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -16.71% -13.22% -82.58% -29.96% -31.67%
EBIT -13.31% -15.55% -71.90% -31.82% -38.62%
EBITDA -15.02% -18.10% -79.31% -34.66% -41.54%
EPS Basic -8.88% 4.15% -54.30% -16.49% -17.44%
Normalized Basic EPS -8.88% 4.17% -49.59% -16.51% -17.44%
EPS Diluted -8.88% 4.15% -54.30% -16.49% -17.44%
Normalized Diluted EPS -8.88% 4.17% -49.59% -16.51% -17.44%
Average Basic Shares Outstanding 7.21% 18.13% 18.32% 11.57% 12.12%
Average Diluted Shares Outstanding 7.21% 18.13% 18.32% 11.57% 12.12%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --